MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-07-0010858
Saswat Pharmaceutical (India) Private Limited
Saswat Pharmaceutical (India) Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.69 Lakh
▲ 9% YoY
Net loss · FY 2025
₹73,815
Net margin -15.7%
EBITDA · FY 2025
-₹70,745
EBITDA margin -15.1%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹12 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Saswat Pharmaceutical (India) Private Limited
Data last updated:
Saswat Pharmaceutical (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 23 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2013PTC239939. Its GSTIN is 21AASCS6573K1ZR (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Dipti Lenka and Nihar Ranjan Lenka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Times Square 7th&8th Flr Cts 349 & 349 – 1 W – E Highway Nr Sai Service Andher(East), Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.69 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹73,815 (net margin -15.7%) and EBITDA of -₹70,745 (EBITDA margin -15.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 8% over five years.
Saswat Pharmaceutical (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-07-0010858). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24297MH2013PTC239939
Registration Number 239939
Incorporation Date 23 January 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-07-0010858
Key People
Dipti Lenka Director Nihar Ranjan Lenka Director Recognitions & Rankings of Saswat Pharmaceutical (India)
Contact details
Saswat Pharmaceutical (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTimes Square 7th&8th Flr Cts 349 & 349 – 1 W – E Highway Nr Sai Service Andher(East), Mumbai, Maharashtra, India – 400069
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Comprehensive company report
Saswat Pharmaceutical (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Saswat Pharmaceutical (India) is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Financials of Saswat Pharmaceutical (India) Private Limited
FY 2025 filings availableSaswat Pharmaceutical (India) Private Limited reported revenue of ₹4.69 Lakh (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹4.69 Lakh ▲ 9%
Net loss · FY 2025
₹73,815 margin -15.7%
EBITDA · FY 2025
-₹70,745 margin -15.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 19%
5 years · compounded
▲ 8%
EBITDA CAGR growth
3 years · compounded
▼ 55%
5 years · compounded
▼ 38%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 9% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹70,745 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹73,815 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.1% | ||||
| Net Profit Margin | -15.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Board of directors of Saswat Pharmaceutical (India) Private Limited
Saswat Pharmaceutical (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipti Lenka | Director | 02 Dec 2016 | 9 Years 11 Months | Current |
| Nihar Ranjan Lenka | Director | 01 Jun 2024 | 2 Years 5 Months | Current |
Peer comparison
Saswat Pharmaceutical (India) Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agr Business Zone India Private Limited | ₹4.82 Lakh (FY 2019) | Panchkula, Haryana, India | ||||
| Saswat Pharmaceutical (India) Private Limitedthis company | ₹4.69 Lakh (FY 2025) | -₹73,815 | -15.7% | 9.0% | Mumbai, Maharashtra, India | |
| Vedikroots Ayurveda Private Limited | ₹4.5 Lakh (FY 2023) | Agra, Uttar Pradesh, India | ||||
| Vedhearbs Healthcare Private Limited | ₹4.42 Lakh (FY 2024) | -64.0% | Delhi, India |
To see the full peer comparison of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Auditor
Saswat Pharmaceutical (India) Private Limited is audited by P C DAS & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P C DAS & CO. | FY 2017 | 068379 |
Shareholding
The shareholding of Saswat Pharmaceutical (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saswat Pharmaceutical (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saswat Pharmaceutical (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saswat Pharmaceutical (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AASCS6573K1ZR | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saswat Pharmaceutical (India) Private Limited, buy the company report.
Recent activity
Saswat Pharmaceutical (India) Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Nihar Ranjan Lenka was appointed as Director on 01 Jun 2024.
AGM
Saswat Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Saswat Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Nihar Ranjan Lenka was appointed as Director.
Appointed
Premananda Lenka was appointed as Director.
Ceased
Dusmanta Kumar Rana ceased to be Director.
Ceased
Nihar Ranjan Lenka ceased to be Director.
Appointed
Dipti Lenka was appointed as Director.
Incorporation
23 Jan 2013
Saswat Pharmaceutical (India) Private Limited was registered on 23 Jan 2013 with Roc Mumbai I & aged 13 years 9 months as per MCA records.
Frequently asked questions
Saswat Pharmaceutical (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 23 January 2013 (13+ years old) and is registered under CIN U24297MH2013PTC239939.
Saswat Pharmaceutical (India) has 2 current directors:
- Dipti Lenka - Director
- Nihar Ranjan Lenka - Director
The latest financial statements of Saswat Pharmaceutical (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Saswat Pharmaceutical (India) is 21AASCS6573K1ZR, registered in Odisha.
The CIN (Corporate Identification Number) of Saswat Pharmaceutical (India) is U24297MH2013PTC239939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saswat Pharmaceutical (India) was incorporated on 23 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Saswat Pharmaceutical (India) by revenue are Agr Business Zone India Private Limited, Vedikroots Ayurveda Private Limited, Vedhearbs Healthcare Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (retail trading).
Nihar Ranjan Lenka was appointed as Director on 01 Jun 2024. Premananda Lenka was appointed as Director on 03 Feb 2017. Dusmanta Kumar Rana ceased to be Director on 27 Jan 2017. Saswat Pharmaceutical (India) has 5 board changes on record in total.
Yes, Saswat Pharmaceutical (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-07-0010858).
The registered office of Saswat Pharmaceutical (India) is at Times Square 7th&8th Flr Cts 349 & 349 – 1 W – E Highway Nr Sai Service AndherEast, Mumbai, Maharashtra, India – 400069.
Saswat Pharmaceutical (India) operates in the healthcare industry, in the ayurvedic products and services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages